References
- World Health Organization (WHO). Antimicrobial resistance: 2014 global report on surveillance. 2014. [cited 2017 Jan 21]. Available from: http://www.who.int/
- Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543:15.
- Ruppé É, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5:21.
- Islamovic S, Galic B, Milos M. A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2 [B3O3F4OH]. J Enzyme Inhib Med Chem. 2014;29:744–748.
- Hadžić M, Haverić S, Haverić A, et al. Inhibitory effects of delphinidin and luteolin on genotoxicity induced by K2 (B3O3F4OH) in human lymphocytes in vitro. Biologia. 2015;70:553–558.
- Ivankovic S, Stojkovic R, Galic Z, et al. In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2 [B3O3F4OH]). J Enzyme Inhib Med Chem. 2015;30:354–359.
- Vullo D, Milos M, Galic B, et al. Dipotassium- trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases. J Enzyme Inhib Med Chem. 2015;30:341–344.
- Ivankovic S, Stojkovic R, Maksimovic M, et al. Impact of calcium ion on cytotoxic effect of the boroxine derivative, K2[B3O3F4OH]]. J Enzyme Inhib Med Chem. 2016;31:70–74.
- Pojskic L, Haveric S, Lojo-Kadric N, et al. Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line. J Enzyme Inhib Med Chem. 2016;31:999–1004.
- Ryss IG, Slutskaya MM. Report on the platinum sector. Akad Nauk SSSR. 1951;26:216–218.
- Maravić A, Skočibušić M, Cvjetan S, et al. Prevalence and diversity of extended-spectrum-β-lactamase-producing Enterobacteriaceae from marine beach waters. Mar Poll Bull. 2015;90:60–67.
- Clinical and Laboratory Standards Institute. Performance Standard for Antimicrobial Susceptibility Testing – Approved Standard M100–S22. Wayne, PA: CLSI; 2012.
- Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- Soon RL, Nation RL, Hartley PG, et al. Atomic force microscopy investigation of the morphology and topography of colistin-heteroresistant Acinetobacter baumannii strains as a function of growth phase and in response to colistin treatment. Antimicrob Agents Chemother. 2009;53:4979–4986.
- Rončević T, Gajski G, Ilić N, et al. PGLa-H tandem-repeat peptides active against multidrug resistant clinical bacterial isolates. Biochim Biophys Acta. 2017;1859:228–237.
- Rončević T, Vukičević D, Ilić N, et al. Antibacterial activity affected by the conformational flexibility in glycine-lysine-based α-helical antimicrobial peptides. J Med Chem. 2018;61:2924–2936.
- Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis. 1998;26:1179–1181.
- DeLeo FR, Chambers HF. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest. 2009;119:2464–2474.
- Rončević T, Vukičević D, Krce L, et al. Selection and redesign for high selectivity of membrane-active antimicrobial peptides from a dedicated sequence/function database. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2019;1861:827–834.
- Bazina L, Maravić A, Krce L, et al. Discovery of novel quaternary ammonium compounds based on quinuclidine-3-ol as new potential antimicrobial candidates. Eur J Med Chem. 2019;163:626–635.
- Rončević T, Krce L, Gerdol M, et al. Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2019;1861:651–659.
- Silva F, Lourenço O, Queiroz JA, et al. Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye. J Antibiot. 2011;64:321.
- Tollersrud T, Berge T, Andersen SR, et al. Imaging the surface of Staphylococcus aureus by atomic force microscopy. APMIS. 2001;109:541–545.
- Dorobantu LS, Gray MR. Application of atomic force microscopy in bacterial research. Scanning. 2010;32:74–96.